Found 1266 with Last Name = 'goehring' and Initial = 'rr' 
Affinity DataKi: 0.0400nMAssay Description:Binding assay of certain compounds of this invention to the opioid receptor was determine using radioligand binding assay (screening and dose-displac...More data for this Ligand-Target Pair
Affinity DataKi: 0.0500nMAssay Description:Binding assay of certain compounds of this invention to the opioid receptor was determine using radioligand binding assay (screening and dose-displac...More data for this Ligand-Target Pair
Affinity DataKi: 0.0500nMAssay Description:Binding assay of certain compounds of this invention to the opioid receptor was determine using radioligand binding assay (screening and dose-displac...More data for this Ligand-Target Pair
Affinity DataKi: 0.0700nMAssay Description:Binding assay of certain compounds of this invention to the opioid receptor was determine using radioligand binding assay (screening and dose-displac...More data for this Ligand-Target Pair
Affinity DataKi: 0.0800nMAssay Description:Binding assay of certain compounds of this invention to the opioid receptor was determine using radioligand binding assay (screening and dose-displac...More data for this Ligand-Target Pair
Affinity DataKi: 0.100nMAssay Description:Binding assay of certain compounds of this invention to the opioid receptor was determine using radioligand binding assay (screening and dose-displac...More data for this Ligand-Target Pair
Affinity DataKi: 0.120nMAssay Description:Binding assay of certain compounds of this invention to the opioid receptor was determine using radioligand binding assay (screening and dose-displac...More data for this Ligand-Target Pair
Affinity DataKi: 0.120nMAssay Description:Binding assay of certain compounds of this invention to the opioid receptor was determine using radioligand binding assay (screening and dose-displac...More data for this Ligand-Target Pair
Affinity DataKi: 0.150nMAssay Description:Binding assay of certain compounds of this invention to the opioid receptor was determine using radioligand binding assay (screening and dose-displac...More data for this Ligand-Target Pair
Affinity DataKi: 0.150nMAssay Description:Binding assay of certain compounds of this invention to the opioid receptor was determine using radioligand binding assay (screening and dose-displac...More data for this Ligand-Target Pair
Affinity DataKi: 0.150nMAssay Description:Binding assay of certain compounds of this invention to the opioid receptor was determine using radioligand binding assay (screening and dose-displac...More data for this Ligand-Target Pair
Affinity DataKi: 0.150nMAssay Description:Affinity to human Bradykinin receptor B2 in CHO cell membranes determined by displacement of [3H]-NPC 17731More data for this Ligand-Target Pair
Affinity DataKi: 0.150nMAssay Description:Binding assay of certain compounds of this invention to the opioid receptor was determine using radioligand binding assay (screening and dose-displac...More data for this Ligand-Target Pair
Affinity DataKi: 0.170nMAssay Description:Binding assay of certain compounds of this invention to the opioid receptor was determine using radioligand binding assay (screening and dose-displac...More data for this Ligand-Target Pair
Affinity DataKi: 0.180nMAssay Description:Inhibition of [3H]nociceptin binding to human Opioid receptor like 1More data for this Ligand-Target Pair
Affinity DataKi: 0.200nM ΔG°: -55.4kJ/molepH: 7.4 T: 2°CAssay Description:Radioligand dose displacement assays used 0.4 nM [3H]-U69,593 (GE Healthcare, Piscataway, N.J.; 40 Ci/mmole) with 15 ug membrane protein (recombinant...More data for this Ligand-Target Pair
Affinity DataKi: 0.210nMAssay Description:Binding assay of certain compounds of this invention to the opioid receptor was determine using radioligand binding assay (screening and dose-displac...More data for this Ligand-Target Pair
Affinity DataKi: 0.230nMAssay Description:Binding assay of certain compounds of this invention to the opioid receptor was determine using radioligand binding assay (screening and dose-displac...More data for this Ligand-Target Pair
Affinity DataKi: 0.230nM ΔG°: -55.0kJ/molepH: 7.4 T: 2°CAssay Description:Radioligand dose displacement assays used 0.4 nM [3H]-U69,593 (GE Healthcare, Piscataway, N.J.; 40 Ci/mmole) with 15 ug membrane protein (recombinant...More data for this Ligand-Target Pair
Affinity DataKi: 0.300nM ΔG°: -54.4kJ/molepH: 7.4 T: 2°CAssay Description:Radioligand dose displacement assays used 0.4 nM [3H]-U69,593 (GE Healthcare, Piscataway, N.J.; 40 Ci/mmole) with 15 ug membrane protein (recombinant...More data for this Ligand-Target Pair
Affinity DataKi: 0.350nMAssay Description:Binding assay of certain compounds of this invention to the opioid receptor was determine using radioligand binding assay (screening and dose-displac...More data for this Ligand-Target Pair
Affinity DataKi: 0.400nMAssay Description:Binding assay of certain compounds of this invention to the opioid receptor was determine using radioligand binding assay (screening and dose-displac...More data for this Ligand-Target Pair
Affinity DataKi: 0.430nMAssay Description:Binding assay of certain compounds of this invention to the opioid receptor was determine using radioligand binding assay (screening and dose-displac...More data for this Ligand-Target Pair
Affinity DataKi: 0.470nM ΔG°: -53.2kJ/molepH: 7.4 T: 2°CAssay Description:Radioligand dose displacement assays used 0.4 nM [3H]-U69,593 (GE Healthcare, Piscataway, N.J.; 40 Ci/mmole) with 15 ug membrane protein (recombinant...More data for this Ligand-Target Pair
Affinity DataKi: 0.530nMAssay Description:Binding assay of certain compounds of this invention to the opioid receptor was determine using radioligand binding assay (screening and dose-displac...More data for this Ligand-Target Pair
Affinity DataKi: 0.570nMAssay Description:Affinity to human Bradykinin receptor B2 in CHO cell membranes determined by displacement of [3H]-NPC 17731More data for this Ligand-Target Pair
Affinity DataKi: 0.590nMAssay Description:Binding assay of certain compounds of this invention to the opioid receptor was determine using radioligand binding assay (screening and dose-displac...More data for this Ligand-Target Pair
Affinity DataKi: 0.600nM ΔG°: -52.6kJ/molepH: 7.4 T: 2°CAssay Description:Radioligand dose displacement assays used 0.4 nM [3H]-U69,593 (GE Healthcare, Piscataway, N.J.; 40 Ci/mmole) with 15 ug membrane protein (recombinant...More data for this Ligand-Target Pair
Affinity DataKi: 0.690nMAssay Description:Binding assay of certain compounds of this invention to the opioid receptor was determine using radioligand binding assay (screening and dose-displac...More data for this Ligand-Target Pair
Affinity DataKi: 0.740nMAssay Description:Binding assay of certain compounds of this invention to the opioid receptor was determine using radioligand binding assay (screening and dose-displac...More data for this Ligand-Target Pair
Affinity DataKi: 0.860nM ΔG°: -56.1kJ/molepH: 7.4 T: 2°CAssay Description:mu-Opioid Receptor Binding Assay Procedures: Radioligand dose-displacement binding assays for mu-opioid receptors used 0.3 nM [3H]-diprenorphine (Per...More data for this Ligand-Target Pair
Affinity DataKi: 0.940nM ΔG°: -51.5kJ/molepH: 7.4 T: 2°CAssay Description:Radioligand dose displacement assays used 0.4 nM [3H]-U69,593 (GE Healthcare, Piscataway, N.J.; 40 Ci/mmole) with 15 ug membrane protein (recombinant...More data for this Ligand-Target Pair
Affinity DataKi: 1nMAssay Description:Binding assay of certain compounds of this invention to the opioid receptor was determine using radioligand binding assay (screening and dose-displac...More data for this Ligand-Target Pair
Affinity DataKi: 1.12nMAssay Description:Binding assay of certain compounds of this invention to the opioid receptor was determine using radioligand binding assay (screening and dose-displac...More data for this Ligand-Target Pair
Affinity DataKi: 1.20nMAssay Description:Binding assay of certain compounds of this invention to the opioid receptor was determine using radioligand binding assay (screening and dose-displac...More data for this Ligand-Target Pair
Affinity DataKi: 1.22nMAssay Description:Binding assay of certain compounds of this invention to the opioid receptor was determine using radioligand binding assay (screening and dose-displac...More data for this Ligand-Target Pair
Affinity DataKi: 1.30nMAssay Description:Binding assay of certain compounds of this invention to the opioid receptor was determine using radioligand binding assay (screening and dose-displac...More data for this Ligand-Target Pair
Affinity DataKi: 1.40nMpH: 7.4Assay Description:Radioligand binding assays (screening and dose-displacement) used 0.1nM [3H]-nociceptin (NEN; 87.7 Cl/nimole) with 10-20 ug membrane protein in a fin...More data for this Ligand-Target Pair
Affinity DataKi: 1.40nMpH: 7.4Assay Description:Radioligand binding assays (screening and dose-displacement) used 0.1nM [3H]-nociceptin (NEN; 87.7 Cl/nimole) with 10-20 ug membrane protein in a fin...More data for this Ligand-Target Pair
Affinity DataKi: 1.47nMAssay Description:Binding assay of certain compounds of this invention to the opioid receptor was determine using radioligand binding assay (screening and dose-displac...More data for this Ligand-Target Pair
Affinity DataKi: 1.55nMAssay Description:Binding assay of certain compounds of this invention to the opioid receptor was determine using radioligand binding assay (screening and dose-displac...More data for this Ligand-Target Pair
Affinity DataKi: 1.60nMpH: 7.4Assay Description:Radioligand binding assays (screening and dose-displacement) used 0.1nM [3H]-nociceptin (NEN; 87.7 Cl/nimole) with 10-20 ug membrane protein in a fin...More data for this Ligand-Target Pair
Affinity DataKi: 1.60nMAssay Description:Binding assay of certain compounds of this invention to the opioid receptor was determine using radioligand binding assay (screening and dose-displac...More data for this Ligand-Target Pair
Affinity DataKi: 1.76nMAssay Description:Binding assay of certain compounds of this invention to the opioid receptor was determine using radioligand binding assay (screening and dose-displac...More data for this Ligand-Target Pair
Affinity DataKi: 1.80nMpH: 7.4Assay Description:Radioligand binding assays (screening and dose-displacement) used 0.1nM [3H]-nociceptin (NEN; 87.7 Cl/nimole) with 10-20 ug membrane protein in a fin...More data for this Ligand-Target Pair
Affinity DataKi: 1.87nMAssay Description:Binding assay of certain compounds of this invention to the opioid receptor was determine using radioligand binding assay (screening and dose-displac...More data for this Ligand-Target Pair
Affinity DataKi: 1.91nMAssay Description:Binding assay of certain compounds of this invention to the opioid receptor was determine using radioligand binding assay (screening and dose-displac...More data for this Ligand-Target Pair
Affinity DataKi: 2nMpH: 7.4Assay Description:Radioligand binding assays (screening and dose-displacement) used 0.1nM [3H]-nociceptin (NEN; 87.7 Cl/nimole) with 10-20 ug membrane protein in a fin...More data for this Ligand-Target Pair
Affinity DataKi: 2nMAssay Description:Binding assay of certain compounds of this invention to the opioid receptor was determine using radioligand binding assay (screening and dose-displac...More data for this Ligand-Target Pair
Affinity DataKi: 2.12nMAssay Description:μ-Opioid: Radioligand dose-displacement binding assays for μ-opioid receptors used 0.3 nM [3H]-diprenorphine (Perkin Elmer, Shelton, Conn.)...More data for this Ligand-Target Pair
